CURRENT HIV RESEARCH

Scope & Guideline

Connecting Researchers, Inspiring Change

Introduction

Explore the comprehensive scope of CURRENT HIV RESEARCH through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore CURRENT HIV RESEARCH in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1570-162x
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2003 to 2024
AbbreviationCURR HIV RES / Curr. HIV Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

CURRENT HIV RESEARCH focuses on a wide array of research topics related to HIV infection, treatment, and prevention. The journal aims to advance the understanding of HIV through a multidisciplinary approach, incorporating clinical research, epidemiology, molecular biology, and pharmacology.
  1. Clinical Research and Epidemiology:
    The journal publishes studies examining the epidemiology of HIV, clinical outcomes, and the effectiveness of various treatment regimens in diverse populations.
  2. Molecular Biology and Genetics:
    Research on the molecular mechanisms of HIV infection, including genetic variations, drug resistance, and viral pathogenesis is a core focus.
  3. Pharmacological Studies:
    The journal highlights pharmacological research, including the development of new anti-HIV agents, drug interactions, and treatment adherence challenges.
  4. Social and Behavioral Aspects of HIV:
    Studies exploring the social determinants of health, stigma, and psychological aspects of living with HIV are also prominent.
  5. Innovative Diagnostic and Treatment Strategies:
    CURRENT HIV RESEARCH emphasizes innovative approaches to diagnosis, treatment, and prevention, including the use of telemedicine and mobile health interventions.
CURRENT HIV RESEARCH has witnessed the emergence of several key themes that reflect the evolving landscape of HIV research. The following points capture the trending topics that are gaining traction.
  1. Impact of COVID-19 on HIV Populations:
    Research addressing the implications of the COVID-19 pandemic on HIV care, testing, and health outcomes has surged, highlighting the intersection of these two global health crises.
  2. HIV Stigma and Social Determinants of Health:
    There is an increasing focus on the social determinants of health, stigma, and mental health issues affecting people living with HIV, indicating a more holistic approach to HIV research.
  3. Innovative Therapeutic Approaches:
    The exploration of novel therapeutic strategies, including mRNA vaccines and gene editing technologies, is on the rise, reflecting advancements in HIV treatment and prevention.
  4. Long-Acting Antiretroviral Therapies:
    Research into long-acting formulations of ART is gaining momentum, indicating a shift towards improving treatment adherence and patient outcomes.
  5. Health Technology and Telemedicine:
    The utilization of telemedicine and mobile health technologies for HIV care delivery is increasingly being examined, especially in the context of improving access and service continuity.

Declining or Waning

While CURRENT HIV RESEARCH has a broad scope, certain themes have shown signs of declining prominence in recent publications. This section outlines these waning topics, indicating possible shifts in research focus.
  1. Traditional ART Strategies:
    Research specifically focused on traditional antiretroviral therapy (ART) strategies appears to be decreasing, with a shift towards exploring long-acting therapies and combination strategies.
  2. Basic Science Studies:
    The proportion of basic science studies focusing solely on HIV virology without clinical implications has diminished, reflecting a trend toward more applied research.
  3. HIV and Co-Infections:
    Although co-infection research remains relevant, the frequency of studies solely focused on HIV co-infections with other diseases, such as tuberculosis or hepatitis, has declined.

Similar Journals

Journal of Clinical Virology Plus

Exploring the frontiers of viral diagnostics and therapies.
Publisher: ELSEVIERISSN: 2667-0380Frequency: 4 issues/year

The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.

ACTA VIROLOGICA

Innovative insights into viral pathogens and their impact.
Publisher: FRONTIERS MEDIA SAISSN: 0001-723XFrequency: 4 issues/year

ACTA VIROLOGICA, a key journal in the field of virology and infectious diseases, is published by FRONTIERS MEDIA SA in Slovakia, serving the global scientific community with groundbreaking research since its inception in 1957. This esteemed journal, identified by ISSN 0001-723X and E-ISSN 1336-2305, provides a platform for rigorous peer-reviewed articles that contribute significantly to our understanding of viral pathogens and their implications in medicine. Positioned within the Q3 category for both Infectious Diseases and Miscellaneous Medicine, and a Q4 category for Virology in 2023, ACTA VIROLOGICA offers crucial insights into the evolving landscape of virology research. With its robust accessibility options, this journal appeals to a diverse readership, including researchers, healthcare professionals, and students, fostering a collaborative environment to advance the field of virology. The editorial objective is to enhance the catalog of knowledge pertaining to viruses, promoting innovative approaches in prevention, diagnostics, and treatment. Located at AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND, ACTA VIROLOGICA continues to be a vital resource in the collective efforts to combat viral disease challenges.

Infectious Agents and Cancer

Unraveling the complex interplay of infectious agents and oncology.
Publisher: BMCISSN: 1750-9378Frequency: 1 issue/year

Infectious Agents and Cancer is a pivotal open access journal published by BMC, dedicated to advancing research at the intersection of infectious diseases and oncology. Since its inception in 2006, this journal has provided a platform for the exploration of the complex relationships between infectious agents and cancer development, aimed at researchers, healthcare professionals, and students alike. With a broad scope encompassing epidemiology and cancer research, the journal holds an impressive ranking in the Q3 quadrant for epidemiology, infectious diseases, and oncology in 2023, while also featuring in the Q4 category for cancer research. This distinguished journal not only contributes to the enrichment of scientific knowledge but also fosters collaborative efforts towards innovative solutions in the fight against cancer. Being part of the UK publishing landscape, the journal is accessible to a global audience, ensuring that vital research findings are disseminated widely to inform policy and practice in health sciences.

SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE

Connecting researchers to elevate HIV treatment and understanding.
Publisher: AOSISISSN: 1608-9693Frequency: 1 issue/year

SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, published by AOSIS, stands as a vital resource in the field of Infectious Diseases, particularly focusing on HIV medicine. With an ISSN of 1608-9693 and E-ISSN 2078-6751, this Open Access journal has been dedicated to disseminating cutting-edge research since 2001, ensuring that findings are accessible to a global audience of researchers, healthcare professionals, and students. Operating out of South Africa, the journal has earned a position in the Q3 quartile for Infectious Diseases, reflecting its commitment to advancing the understanding and treatment of HIV-related issues. Its Scopus ranking, presently at #207 out of 344, further emphasizes its scholarly influence, positioning it as an essential publication within the medical community. The journal aims to foster collaboration and innovation in HIV research and practice, bridging gaps between theory and real-world application to improve health outcomes in southern Africa and beyond.

VIROLOGIE

Fostering knowledge in the evolving world of virology.
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1267-8694Frequency: 6 issues/year

VIROLOGIE is a prominent international journal dedicated to advancing the field of virology and infectious diseases, published by John Libbey Eurotext Ltd. Since its inception in 1997, this journal has provided a platform for researchers and professionals to disseminate their findings on various aspects of virology, including the pathogenesis, epidemiology, and treatment of viral infections. Despite its current ranking in Q4 for both Infectious Diseases and Virology categories, the journal remains a valuable resource for emerging research and novel insights. The ISSN for the journal is 1267-8694, and it is based in France. VIROLOGIE is committed to upholding rigorous academic standards and fosters an inclusive scholarly community, making it an essential read for those pursuing knowledge and advancements in the ever-evolving landscape of virology. While the journal does not currently offer open access options, it continues to contribute significantly to the global discourse on viral research through its diverse range of published studies.

Infection and Drug Resistance

Illuminating the path to effective therapeutic interventions.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6973Frequency: 1 issue/year

Infection and Drug Resistance, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the critical fields of infectious diseases and pharmacology. Since its establishment in 2008, this journal has emerged as a vital resource for researchers, professionals, and students alike, offering thorough insights into the mechanisms of drug resistance and the effectiveness of various therapeutic interventions. With an impressive 2023 impact factor placing it in the Q2 category across multiple relevant disciplines, including Infectious Diseases and Pharmacology, it serves as a significant platform for high-quality research dissemination. Infection and Drug Resistance aims to foster a deeper understanding of the evolving challenges in managing infectious diseases and enhancing drug efficacy, contributing to the global discourse on public health. The journal's commitment to open access ensures that vital knowledge is readily available to promote broader scholarly engagement and innovation.

Frontiers in Virology

Pioneering Discoveries in Viral Pathogenesis
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Virology, published by FRONTIERS MEDIA SA, is an innovative open-access journal dedicated to advancing the understanding of viral biology, pathogenesis, surveillance, and control strategies. With the rapid evolution of viral threats, this journal serves as a critical platform for researchers, professionals, and students to disseminate and access high-quality research, reviews, and perspectives in virology. The journal places a strong emphasis on interdisciplinary approaches, promoting collaborative efforts that drive breakthroughs in the field. While the specific impact factor and H-index details are currently unavailable, Frontiers in Virology is committed to rigorous peer review and integrity in scientific publishing. Authors and readers will benefit from the extensive reach provided by open access, making groundbreaking insights available to a global audience, thus contributing significantly to the ongoing dialogue in virology and public health.

AIDS RESEARCH AND HUMAN RETROVIRUSES

Transforming Knowledge into Action Against HIV
Publisher: MARY ANN LIEBERT, INCISSN: 0889-2229Frequency: 12 issues/year

AIDS RESEARCH AND HUMAN RETROVIRUSES, published by Mary Ann Liebert, Inc., is a pivotal journal dedicated to advancing the field of HIV research and the broader spectrum of human retroviruses. With an ISSN of 0889-2229 and an E-ISSN of 1931-8405, this journal has been in continuous publication since 1987 and is respected in the academic community for its rigorous peer-reviewed articles. As a Q3 ranked journal in Immunology, Infectious Diseases, and Virology as of 2023, it plays a crucial role in disseminating cutting-edge research, theoretical advancements, and clinical insights that contribute significantly to the understanding and treatment of HIV and related disorders. The journal's objective is to foster collaboration among researchers, healthcare professionals, and educators by providing a platform for the exchange of innovative ideas and findings. Although not an open-access journal, its compelling content ensures that it remains a primary resource for those in the academic and medical communities tackling the challenges posed by retroviral infections. With a commitment to excellence and relevance, AIDS RESEARCH AND HUMAN RETROVIRUSES continues to shape the future of research in this critical area.

Tropical Medicine and Health

Elevating the discourse on tropical medicine and health.
Publisher: BMCISSN: 1348-8945Frequency: 1 issue/year

Tropical Medicine and Health is a prestigious open-access journal published by BMC that serves as a vital platform for researchers and health professionals focusing on the fields of tropical medicine, infectious diseases, and public health. With an ISSN of 1348-8945 and an E-ISSN of 1349-4147, the journal has established itself in the academic community since its inception in 2004, bridging the gap between research and real-world applications in managing tropical diseases. Recognized for its quality, it holds a commendable Q2 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories, positioned in the 2023 Scopus rankings within the 85th and 74th percentiles, respectively. Researchers can access high-quality, peer-reviewed articles that contribute significantly to advancing knowledge in the field. With a commitment to fostering open scientific dialogue, Tropical Medicine and Health is not just a journal, but a collaborative space for researchers, students, and practitioners working to improve health outcomes in tropical regions worldwide.

Lancet HIV

Pioneering knowledge in HIV epidemiology and treatment.
Publisher: ELSEVIER INCISSN: 2352-3018Frequency: 12 issues/year

The Lancet HIV, published by Elsevier Inc in the United Kingdom, stands at the forefront of HIV research and public health, providing a vital platform for the dissemination of innovative findings and critical knowledge in the fields of epidemiology, immunology, infectious diseases, and virology. With its prestigious Q1 rankings in the aforementioned categories for 2023, the journal is recognized for its significant contribution to advancing understanding and addressing challenges posed by HIV globally. Its impressive standing, including a Scopus ranking in the 94th percentile for multiple categories, underscores its impact within the research community. The Lancet HIV publishes rigorously peer-reviewed research articles, reviews, and opinion pieces, ensuring that all stakeholders—researchers, practitioners, and policymakers—are engaged with up-to-date, evidence-based perspectives. Researchers and students alike will find this journal an invaluable resource for enhancing their knowledge and contributing to the ongoing discourse surrounding HIV treatment and prevention.